Featured Press Releases

SK bioscience Receives WHO Prequalification for Typhoid Conjugate Vaccine

SK bioscience Receives WHO Prequalification for Typhoid Conjugate Vaccine

AISA Pharma receives FDA orphan drug designation for AISA-021, a treatment for systemic sclerosis

AISA Pharma receives FDA orphan drug designation for AISA-021, a treatment for systemic sclerosis

  • 09 Sep 2024

Aisa Pharma, Inc. a private, clinical-stage biopharmaceutical company announced that the U.S. Food and...

Daicel Arbor Biosciences and Element Biosciences announce a new grant opportunity, accelerating agrigenomics

Daicel Arbor Biosciences and Element Biosciences announce a new grant opportunity, accelerating agrigenomics

Gvoke VialDx™ (glucagon injection) Launched by American Regent

Gvoke VialDx™ (glucagon injection) Launched by American Regent

New long-term data confirms TREMFYA® (guselkumab) as the only IL-23 inhibitor proven to block joint damage in active psoriatic arthritis

New long-term data confirms TREMFYA® (guselkumab) as the only IL-23 inhibitor proven to block joint damage in active psoriatic arthritis

Nuvation Bio unveils new data on IBTROZI™ (taletrectinib) in advanced ROS1-positive non-small cell lung cancer

Nuvation Bio unveils new data on IBTROZI™ (taletrectinib) in advanced ROS1-positive non-small cell lung cancer

PureTech Secures U.S. and EU Orphan Designations for Deupirfenidone (LYT-100) in IPF

PureTech Secures U.S. and EU Orphan Designations for Deupirfenidone (LYT-100) in IPF

  • PureTech Health plc
  • 20 Feb 2026
ENFLONSIA™ (clesrovimab) shows positive new results in infants and children under 2 at increased risk of severe RSV disease across two seasons, Merck reports

ENFLONSIA™ (clesrovimab) shows positive new results in infants and children under 2 at increased risk of severe RSV disease across two seasons, Merck reports

  • Merck & Co., Inc.
  • 19 Feb 2026
Gantry-less upright proton therapy for lung cancer re-irradiation shows first-ever prospective clinical results, announced by P-Cure

Gantry-less upright proton therapy for lung cancer re-irradiation shows first-ever prospective clinical results, announced by P-Cure

  • P-Cure
  • 17 Feb 2026
To strengthen global AI, data strategy, evidence synthesis, and economic modelling capabilities, Precision AQ expands its senior leadership team

To strengthen global AI, data strategy, evidence synthesis, and economic modelling capabilities, Precision AQ expands its senior leadership team

  • Precision AQ
  • 17 Feb 2026
New ECCO data demonstrate that subcutaneous infliximab (Remsima™ SC) recaptures and maintains disease control following a drug holiday

New ECCO data demonstrate that subcutaneous infliximab (Remsima™ SC) recaptures and maintains disease control following a drug holiday

  • Celltrion
  • 16 Feb 2026
Breakthrough in Zika Virus Drug Discovery Reported by IRBM

Breakthrough in Zika Virus Drug Discovery Reported by IRBM

  • IRBM
  • 14 Feb 2026
World Drug Delivery Summit 2025
The Digital Pharma Advances Conference 2026

Most Popular
February   2026
M T W T F S S
            1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28  

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.